DRÁPELA, Stanislav, Jan BOUCHAL, Mohit Kumar JOLLY, Zoran CULIG and Karel SOUČEK. ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance. Frontiers in Molecular Biosciences. Lausanne: Frontiers Media SA, 2020, vol. 7, No 36, p. 1-10. ISSN 2296-889X. Available from: https://dx.doi.org/10.3389/fmolb.2020.00036.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance
Authors DRÁPELA, Stanislav (203 Czech Republic, belonging to the institution), Jan BOUCHAL (203 Czech Republic), Mohit Kumar JOLLY, Zoran CULIG and Karel SOUČEK (203 Czech Republic, guarantor, belonging to the institution).
Edition Frontiers in Molecular Biosciences, Lausanne, Frontiers Media SA, 2020, 2296-889X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.246
RIV identification code RIV/00216224:14310/20:00115785
Organization unit Faculty of Science
Doi http://dx.doi.org/10.3389/fmolb.2020.00036
UT WoS 000525671300001
Keywords in English ZEB1; plasticity; DNA damage response; therapy resistance; EMT-epithelial to mesenchymal transition
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 16/11/2020 13:38.
Abstract
The predominant way in which conventional chemotherapy kills rapidly proliferating cancer cells is the induction of DNA damage. However, chemoresistance remains the main obstacle to therapy effectivity. An increasing number of studies suggest that epithelial-to-mesenchymal transition (EMT) represents a critical process affecting the sensitivity of cancer cells to chemotherapy. Zinc finger E-box binding homeobox 1 (ZEB1) is a prime element of a network of transcription factors controlling EMT and has been identified as an important molecule in the regulation of DNA damage, cancer cell differentiation, and metastasis. Recent studies have considered upregulation of ZEB1 as a potential modulator of chemoresistance. It has been hypothesized that cancer cells undergoing EMT acquire unique properties that resemble those of cancer stem cells (CSCs). These stem-like cells manifest enhanced DNA damage response (DDR) and DNA repair capacity, self-renewal, or chemoresistance. In contrast, functional experiments have shown that ZEB1 induces chemoresistance regardless of whether other EMT-related changes occur. ZEB1 has also been identified as an important regulator of DDR by the formation of a ZEB1/p300/PCAF complex and direct interaction with ATM kinase, which has been linked to radioresistance. Moreover, ATM can directly phosphorylate ZEB1 and enhance its stability. Downregulation of ZEB1 has also been shown to reduce the abundance of CHK1, an effector kinase of DDR activated by ATR, and to induce its ubiquitin-dependent degradation. In this perspective, we focus on the role of ZEB1 in the regulation of DDR and describe the mechanisms of ZEB1-dependent chemoresistance.
Links
EF16_025/0007381, research and development projectName: Preklinická progrese nových organických sloučenin s cílenou biologickou aktivitou
PrintDisplayed: 26/5/2024 07:14